These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 30091508

  • 21. Evaluation of biochemical and clinical markers of endothelial dysfunction and their correlation with urinary albumin excretion in patients with type 1 diabetes mellitus.
    Polat SB, Ugurlu N, Aslan N, Cuhaci N, Ersoy R, Cakir B.
    Arch Endocrinol Metab; 2016 Apr; 60(2):117-24. PubMed ID: 26886090
    [Abstract] [Full Text] [Related]

  • 22. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
    Wang S, Wang Y, Zheng R, Zhao Z, Ma Y.
    Int J Clin Exp Pathol; 2015 Apr; 8(3):3110-5. PubMed ID: 26045825
    [Abstract] [Full Text] [Related]

  • 23. Correlation between serum carnosinase concentration and renal damage in diabetic nephropathy patients.
    Zhou Z, Liu XQ, Zhang SQ, Qi XM, Zhang Q, Yard B, Wu YG.
    Amino Acids; 2021 May; 53(5):687-700. PubMed ID: 33811534
    [Abstract] [Full Text] [Related]

  • 24. "Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL.
    Lacquaniti A, Donato V, Pintaudi B, Di Vieste G, Chirico V, Buemi A, Di Benedetto A, Arena A, Buemi M.
    Acta Diabetol; 2013 Dec; 50(6):935-42. PubMed ID: 23754672
    [Abstract] [Full Text] [Related]

  • 25. Early Diabetic Nephropathy and Retinopathy in Patients with Type 1 Diabetes Mellitus Attending Sudan Childhood Diabetes Centre.
    Ahmed H, Elshaikh T, Abdullah M.
    J Diabetes Res; 2020 Dec; 2020():7181383. PubMed ID: 33299891
    [Abstract] [Full Text] [Related]

  • 26. Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy.
    Nasser M, Ibrahim KMF, Elnabawi WM, Ahmed TM.
    Egypt J Immunol; 2020 Jun; 27(2):81-92. PubMed ID: 33548980
    [Abstract] [Full Text] [Related]

  • 27. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC, Susanto H, Chuang WH, Liu TY, Wang CH.
    Cardiovasc Diabetol; 2016 Jan 07; 15():3. PubMed ID: 26739836
    [Abstract] [Full Text] [Related]

  • 28. Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus.
    Baek JH, Lee WJ, Lee BW, Kim SK, Kim G, Jin SM, Kim JH.
    Diabetes Metab J; 2021 Jan 07; 45(1):46-54. PubMed ID: 32662254
    [Abstract] [Full Text] [Related]

  • 29. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
    Li W, Wang J, Ge L, Shan J, Zhang C, Liu J.
    Clin Exp Hypertens; 2017 Jan 07; 39(4):382-387. PubMed ID: 28513288
    [Abstract] [Full Text] [Related]

  • 30. Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications.
    Sherif EM, El Maksood AAA, Youssef OI, Salah El-Din NY, Khater OKM.
    J Diabetes Complications; 2019 Sep 07; 33(9):628-633. PubMed ID: 31301955
    [Abstract] [Full Text] [Related]

  • 31. Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.
    Li Q, Feng L, Li J, Chen Q.
    Endocrine; 2014 May 07; 46(1):83-9. PubMed ID: 23943254
    [Abstract] [Full Text] [Related]

  • 32. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H, Bai X, Gao H, Li L, Wu C, Sun X, Zhang C, Shen Y, Zhang J, Lu Z.
    J Diabetes Complications; 2014 May 07; 28(1):96-100. PubMed ID: 24075693
    [Abstract] [Full Text] [Related]

  • 33. Endocan and albuminuria in type 2 diabetes mellitus.
    Cikrikcioglu MA, Erturk Z, Kilic E, Celik K, Ekinci I, Yasin Cetin AI, Ozkan T, Cetin G, Dae SA, Kazancioglu R, Erkoc R.
    Ren Fail; 2016 Nov 07; 38(10):1647-1653. PubMed ID: 27756187
    [Abstract] [Full Text] [Related]

  • 34. Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy.
    Xu T, Xu X, Zhang L, Zhang K, Wei Q, Zhu L, Yu Y, Xiao L, Lin L, Qian W, Wang J, Ke M, An X, Liu S.
    Front Endocrinol (Lausanne); 2021 Nov 07; 12():781417. PubMed ID: 34956093
    [Abstract] [Full Text] [Related]

  • 35. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
    Liu Q, Wang M, Xu T, Liang W, Yang F.
    J Clin Lab Anal; 2022 Feb 07; 36(2):e24210. PubMed ID: 34964177
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.
    Bjornstad P, Wiromrat P, Johnson RJ, Sippl R, Cherney DZI, Wong R, Rewers MJ, Snell-Bergeon JK.
    Diabetes Care; 2019 Feb 07; 42(2):297-302. PubMed ID: 30482755
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Role of urinary podocalyxin in early diagnosis of diabetic nephropathy.
    Kostovska I, Trajkovska KT, Cekovska S, Topuzovska S, Kavrakova JB, Spasovski G, Kostovski O, Labudovic D.
    Rom J Intern Med; 2020 Dec 01; 58(4):233-241. PubMed ID: 32780718
    [Abstract] [Full Text] [Related]

  • 40. Diagnostic efficacy of serum and urinary netrin-1 in the early detection of diabetic nephropathy.
    Elkholy RA, Younis RL, Allam AA, Hagag RY, Abdel Ghafar MT.
    J Investig Med; 2021 Aug 01; 69(6):1189-1195. PubMed ID: 33863755
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.